If you’re at Cowen today, be sure to catch Jeff Goater, CEO, at his 12 p.m. fireside chat discussing Surface Oncology’s two lead antibody programs for cancer targeting CD39 and IL-27. #CowenHealthCare https://t.co/FNgrfcY0M9
If you’re at Cowen today, be sure to catch Jeff Goater, CEO, at his 12 p.m. fireside chat discussing Surface Oncology’s two lead antibody programs for cancer targeting CD39 and IL-27. #CowenHealthCare https://t.co/FNgrfcY0M9